x Health Men's Health Children's Health Nutrition and Wellness Reproductive Health Health & Science Digital News Videos Opinions Cartoons Education E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise BULK SMS E-Learning Digger Classified The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
Login ×

Covid-19: Drug for cats 'could protect humans from virus', scientists claim

Health & Science - By Mirror | August 29th 2020 at 10:45:27 GMT +0300

With coronavirus cases around the world now at over 24 million, scientists have been working around the clock to develop a treatment.

Now, scientists from the University of Alberta claim that a drug designed for cats could protect humans from Covid-19.

The drug, called GC376 is used to treat cats from an illness called feline infectious peritonitis.

However, early studies have shown that the drug can also protect cats from Covid-19, indicating it could also be beneficial in humans.

Covid 19 Time Series


In their study, published in Nature Communications, the researchers, led by Wayne Vuong, wrote: “They are strong drug candidates for the treatment of human coronavirus infections because they have already been successful in animals.

“The work here lays the framework for their use in human trials for the treatment of COVID-19.”

Feline infectious peritonitis is caused by another coronavirus, called feline enteric coronavirus (FCoV).

In the study, the researchers discovered that GC376 works by blocking an enzyme produced by FCoV, preventing the virus from reproducing.

Amazingly, tests revealed that GC376 can also prevent SARS-CoV-2 from replicating.

Best of all, the drugs did not appear to have any toxic side effects, indicating they could be safe for humans.

The researchers added: “Clearly, these drugs need to be advanced quickly into human trials for COVID-19.”


Stay Ahead!

Access premium content only available
to our subscribers.

Support independent journalism
Log in
Support independent journalism
Create an account    Forgot Password
Create An Account
Support independent journalism
I have an account Log in
Reset Password
Support independent journalism
Log in